Bhat, Tariq A.
Kalathil, Suresh G.
Leigh, Noel
Hutson, Alan
Goniewicz, Maciej L.
Thanavala, Yasmin M.
Funding for this research was provided by:
National Cancer Institute, USA (P30CA016056)
National Heart, Lung, and Blood Institute (R01 HL142511)
the US Food and Drug Administration (FDA), and the National Cancer Institute Grant (U54CA228110)
Article History
Received: 8 September 2023
Accepted: 18 October 2023
First Online: 31 October 2023
Declarations
:
: All mice were maintained in a specific pathogen-free environment in barrier facilities at the Roswell Park Comprehensive Cancer Center in Buffalo, NY, with a light/dark cycle of 12/12 h. Animal procedures were approved by the Institutional Animal Care and Use Committee and complied with all state, federal, and NIH regulations.
: MLG reports research grant from Pfizer and personal fees from Johnson & Johnson, outside of this work. Others report none.